Plain-English translation of NCT07045948 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our COPD research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is tracking how your lungs and airway inflammation change over time if you have COPD. Researchers will measure inflammation using a simple breath test and a small blood sample, then follow you for one year to see how these markers evolve and whether they differ between people whose symptoms worsen and those who stay stable.
Doctors want to better understand which patients with COPD are more likely to experience symptom flare-ups and which will remain stable, so they can eventually provide more personalized care and catch problems earlier.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic three times over one year — at the start, 6 months later, and 12 months later. At each visit, you'll do a simple breath test to measure airway inflammation and have a small blood sample taken to check certain white blood cells. All of this fits into your regular COPD care, and your standard treatment will not change.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Belgium
Sponsor
Universitair Ziekenhuis Brussel
Enrollment target
~100 participants
Started
July 2025
Primary completion
June 2027
Age range
40 Years and older
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Naomi Michotte, MD
Universitair Ziekenhuis Brussel
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.